Related Experiment Video
Updated: Jul 31, 2026
Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
Characterization of [3H]Met-enkephalin-Arg6-Phe7 binding to multiple sites in rat and guinea pig cerebellum
1Institute of Biochemistry, Biological Research Centre, Hungarian Academy of Sciences, Szeged. benyhe@everx.szbk.u-szeged.hu
Abstract:
[3H]Met-enkephalin-Arg6-Phe7 (MERF) has been shown to label opioid (kappa2 and delta) and sigma2 sites in rat and frog brain membrane preparations, and no specific binding to kappa1 opioid receptors could be established (refs. 6 and 8). In this study the binding was examined in rat cerebellar membranes which are relatively rich in kappa2-sites, and in guinea pig cerebellar preparations where kappa1 opioid receptors are almost exclusively present. In accordance with our previous results, [3H]MERF binding could not be displaced in guinea pig cerebellar membranes neither with U-69,593 nor with naloxone or levorphanol suggesting no interaction with opioid sites, nevertheless a Kd of 2.8 nM was calculated in cold saturation experiments. In rat cerebellar membrane fractions about the half of the specific [3H]MERF binding sites was inhibited by opiate alkaloids such as naloxone, ethylketocyclazocine, or bremazocine. This portion of the heptapeptide binding sites was stereoselective as demonstrated by the difference in the affinities of the enantiomeric compounds levorphanol and dextrorphan, therefore it would represent an opioid site. In both tissues (-)N-allyl-normetazocine (SKF-10,047), which is also considered as sigma2 ligand, displayed the highest affinities. Among opioid peptides beta-endorphin and dynorphin(1-13) showed the highest potencies, displacing [3H]MERF also from its non-opioid sites. It was concluded therefore that [3H]MERF does not bind to kappa1 sites, and besides kappa2-opioid sites substantial binding to peptide preferring non-opioid sites, and/or sigma2 receptors also occurs.
Insights
[3H]Met-enkephalin-Arg6-Phe7 ([3H]MERF) binds to kappa2-opioid and sigma2 receptors in rat cerebellum, but not kappa1 opioid receptors in guinea pig cerebellum. This peptide ligand interacts with multiple receptor types beyond traditional opioid sites.
Area of Science:
- Neuroscience
- Pharmacology
- Biochemistry
Background:
- Opioid receptors (kappa1, kappa2, delta) and sigma2 sites are crucial in neurological processes.
- [3H]Met-enkephalin-Arg6-Phe7 ([3H]MERF) is a radioligand with known affinity for certain opioid and sigma2 sites.
- Previous studies indicated [3H]MERF does not bind to kappa1 opioid receptors.
Purpose of the Study:
- To investigate the binding characteristics of [3H]MERF in rat and guinea pig cerebellar membranes.
- To differentiate between opioid and non-opioid binding sites for [3H]MERF.
- To clarify the receptor interactions of [3H]MERF, particularly concerning kappa1 and kappa2 opioid receptors and sigma2 sites.
Main Methods:
- Radioligand binding assays using [3H]MERF on rat and guinea pig cerebellar membranes.
- Displacement studies with various opioid alkaloids (naloxone, ethylketocyclazocine, bremazocine, levorphanol, dextrorphan) and sigma2 ligands (SKF-10,047).
- Saturation experiments to determine binding affinity (Kd) and receptor density.
Main Results:
- In guinea pig cerebellum, [3H]MERF binding was not displaced by kappa1-selective ligands, confirming no kappa1 opioid receptor interaction.
- In rat cerebellum, approximately 50% of [3H]MERF binding was inhibited by opioid alkaloids, indicating stereoselective opioid site interaction (likely kappa2).
- [3H]MERF also showed high affinity for non-opioid sites, including sigma2 receptors, as evidenced by displacement with SKF-10,047 and potent inhibition by beta-endorphin and dynorphin(1-13).
Conclusions:
- [3H]MERF does not bind to kappa1 opioid receptors.
- [3H]MERF binds to kappa2-opioid receptors in rat cerebellum.
- Significant binding of [3H]MERF occurs at peptide-preferring non-opioid sites and/or sigma2 receptors, highlighting its polyvalent ligand nature.
